Therapeutic use of vasodilator drugs depends on the differential actions of these drugs on regional vascular beds. These differences include selective action on small and large arteries, differential potency on arterial and venous smooth muscle, and selectivity for autonomic receptors. The directly acting sodium nitroprusside and glyceryl trinitrate exemplify many of these differences as well as shared effects in the systemic, coronary and cerebral circulations.
Vasodilator drugs act by the relaxation of vascular smooth muscle. They may act at any point from the autonomic ganglion to the smooth muscle cell. Drugs which lower vasomotor tone by pharmacological action at sites central to the autonomic ganglia are not regarded primarily as vasodilators and will not be considered here.
Vasodilatation may be produced in part of the vascular bed to obtain secondary changes in another part of the circulatory system. Examples of this include deliberate hypotension for surgery, alteration of vascular impedance in left ventricular failure, and venodilatation in acute myocardial ischaemia.
An example of the rational use of vasodilatation as a therapeutic intervention in cardiovascular disease was given by T. Lauder Brunton in 1867. 1 In July of that year he described the use of amyl nitrite in angina pectoris, recognising that reduction of arterial pressure secondary to peripheral vasodilatation would be of potential benefit during the 'M.B., Ph. D., F.F.A.R.C.S., F.F.A.R.A.C.S., Director of Anaesthesia. ischaemic attack. Unfortunately he was a century too early: when glyceryl trinitrate was introduced into the therapy of angina pectoris 12 years later by William Murrell in 1879,2 the erroneous concept of the desirability of coronary as distinct from peripheral vasodilatation became firmly fixed in the minds of both investigators and clinicians. This notion was only successfully questioned in recent years.3
VASCULAR SMOOTH MUSCLE AND
CiRCULATORY CONTROL The smooth muscle of the blood vessel wall regulates the orderly distribution of blood flow throughout the body. A combination of central nervous control and local tissue factors modulate the activity of the smooth muscle, which is normally in a state of partial contraction or tone. Despite the well marked variation in the type of control which predominates in individual tissues, vasodilator drugs decrease the contraction of the smooth muscle, regardless of whether this is locally or remotely produced.
The observed variation in responses to drugs which ultimately result in relaxation or inhibition of contraction of vascular smooth muscle can be explained in part by the great physiological variation in the type and density of autonomic innervation. In addition, the number and type of pharmacological receptors which respond to endogenous and exogenous vasoactive substances is important. More recently, evidence has been produced that significant differences may exist in the ability of drugs to act at receptors depending on whether they are prejunctional or postjunctional, the junctional zone being the neuronal-smooth muscle interface. 4 ,5 
Division of the Peripheral Circulation into Functional Sections
Mellander and Johanssen 6 have reviewed the division of the circulation into reasonably distinct functioning units as follows:
Large and Medium Elastic Arteries
These perform the first stage of smoothing flow into the smaller vessels, and may account for up to 10070 of the overall pressure drop across the circulation. The smooth muscle in these arteries is more or less "tonic" with relatively slow responses compared with smaller muscular arteries. 7 
Precapillary Resistance Vessels
About 60% of the total pressure drop occurs across these smaller arteries and the arterioles. The precapillary sphincters are the smallest resistance vessels in which smooth muscle contraction can lead to closure of the capillary entrance, and they therefore regulate the number of patent capillaries.
The state of partial contraction or myogenic tone is well established in the precapillary resistance vessels. This tonic activity is maintained partly by phasic activity propagated from cell to cell.
Vasodilatation at the precapillary resistance level may involve at least two types of autonomic receptors. In skeletal muscle and skin, sympathetic cholinergic fibres innervate the vessels but are normally only unmasked to stimulation after adrenergic receptor blockade. 8 Atropine will block these vasodilator responses. There is no evidence that these cholinergic sympathetic vasodilator fibres innervate the capacitance vessels. In addition to the cholinergic vasodilator mechanism, there are beta-adrenoreceptors on the precapillary resistance vessels which can be demonstrated in Anaesthesia and Intensive Care, Vo/. VIII, No. 3, August, 1980 experimental preparations by sympathetic nerve stimulation after combined alphaadrenoreceptor and cholinoreceptor blockade. There is no convincing evidence that neural reflex activation contributes to stimulation of these beta-adrenoreceptors.
Postcapillary Resistance Vessels
These small veins and venules are able to contribute to about 15% of the pressure drop across the circulation. However, they are of greater significance in controlling the capillary hydrostatic pressure, and also in being a source (or sink) for rapid mobilisation of blood.
The ratio of the precapillary to postcapillary resistance, normally about 4 to 1, is important as it determines the capillary hydrostatic pressure and hence fluid filtration. Drugs which can modify this ratio will also cause fluid shift by filtration or absorption.
The postcapillary resistance vessels, with few exceptions, have little inherent activity and are largely under remote reflex controU This allows rapid mobilisation or sequestration of a significant fraction of circulating blood volume via these low pressure vessels. This ability to store large volumes is shared with capacitance vessels.
Capacitance Vessels
Because they contain some 80% of regional blood volume, changes in the activity of smooth muscle in the walls of these vessels can produce haemodynamically important shifts in regional blood content and so influence venous return, cardiac filling pressures and cardiac output.
Control of Smooth Muscle Activity in Veins
The smooth muscle of the vein wall, as in the arteriole, contains alpha-adrenoreceptors which are innervated by sympathetic vasomotor fibres. Thus, noradrenaline, adrenaline and sympathomimetic drugs can produce constriction. This constriction may be inhibited by drugs which block the alpha-adrenoreceptor such as phentolamine and prazosin.
As in the arteriole, venous smooth muscle also has beta-adrenoreceptors which cause relaxation or inhibition of contraction when activated. The venous receptors differ from the arteriolar receptors in that it is necessary to produce some initial constriction before they can be demonstrated. 9 The degree of receptor activation due to circulating catecholamines in the resting and activated state is not established, but experimental data from the cat would suggest that there is alpha-adrenoreceptor stimulation at the threshold level in the resting state, and that beta-2-adrenoreceptor stimulation would only result when there is an increase in catecholamine secretion above the resting level. This would also suggest that the adrenergic vasodilator mechanism may be brought into activity to modulate the background of basal contraction of smooth muscle in the vessel wa11. 10 The relative involvement of the precapillary and postcapillary vessels in this postulated mechanism is not yet understood.
Although different veins may have qualitatively similar autonomic innervation and receptors, they vary from tissue to tissue in at least two important features; these are the density of the adrenergic innervation as measured by the catecholamine content, and the density of the smooth muscle cell population as measured by the constrictor response to noradrenaline. 11 The catecholamine content of the walls is high in cutaneous, mesenteric and splenic veins, but low in deeper limb veins (draining muscle) and jugular veins. Thus cutaneous and splanchnic veins constrict vigorously in response to stimulation of the adrenergic nerves, while deeper limb veins respond minimally to nerve stimulation compared with their response to exogenous noradrenaline. This means that vasodilator drugs which act "directly" on smooth muscle and not via autonomic mechanisms would be expected to particularly affect the veins draining the muscles and the limbs with their denser smooth muscle. Directly acting drugs will be able to cause considerable sequestration of blood into the muscular buffer. Small changes in the control of muscle blood flow can therefore result in large changes of overall circulatory function.
In contrast, drugs which cause vasodilatation by blockade of alpha-adrenoreceptors would be expected to affect cutaneous and splanchnic veins more than those draining skeletal muscle. Thus an alpha-adrenoreceptor antagonist such as prazosin would exert its cardiovascular actions with less venous pooling than a directly acting smooth muscle relaxant such as glyceryl trinitrate which is primarily a peripheral venodilator .12,13
Classification of Vasodilator Drugs
Drugs acting on different cardiovascular receptors may be classified according to their principal site of action. Vasodilator drugs often act simultaneously at several sites, and without exception details of the mechanisms of their effect on smooth muscle are either unknown or disputed. Most drugs which are not known to act at specific autonomic receptors are classed as "directly" acting. A classification which may be used is:
1. Alpha-adrenoreceptor antagonists.
2. Beta-adrenoreceptor agonists.
3. Ganglion blocking drugs. 4. Direct vasodilators.
The last group accounts for most of the currently used agents, with increasing interest in alpha-adrenoreceptor antagonists.
Mechanisms of Direct Vasodilatation
Considerable effort has gone into attempts to establish a common mechanism to account for the relaxation of vascular smooth muscle at the subcellular level by different drugs. A possible common factor is the role which cytoplasmic calcium ion activity plays in determining the activity of the myofibril. The cytoplasmic calcium ion activity is determined by a dynamic balance between a number of variable subsystems. These include the influx of calcium into the cytoplasm, its release from binding and storage sites, particularly from the sarcoplasmic reticulum, and its return to these sites, and removal of calcium ion by active extrusion from the cell. Relaxation of smooth muscle will result from the disturbance of any of these subsystems favouring a lowering of cytoplasmic calcium ion concentration. 14 In addition, Somlyo and Somlyo have proposed a possible desensitisation of contractile protein to the calcium ion. 15 MacKenzie and Parratt have also suggested that organic nitrates may at least in part stimulate adenyl cyclase,16 since both isoprenaline and glyceryl trinitrate are potentiated by phosphodiesterase inhibitors such as theophylline. 17 The localisation of this action is distal to the beta -adrenoreceptor, since it is unaffected by propranolol. This action Anaesthesia and intensive Care, Vol. VIII, No. 3, August, 1980 does not appear to be shared by nitroprusside.
Kreye et al. failed to find any increase in levels of cyclic AMP in rat aortic tissue after incubation with sodium nitroprusside. 18 This ion is a large anion with low charge density and may act by increasing the negativity of intracellular membrane surfaces and thus enhance passive divalent cation binding. 14 CARDIOVASCULAR RESPONSES TO VASODILATOR DRUGS 1. Vasodilatation, ventricular afterload and arterial impedance.
The reduction of preload and afterload which may accompany vasodilatation will directly affect cardiac output, and indirectly this will be modified by induced changes in contractility and heart rate. The ventricular preload is the wall stress at end-diastole and bears a complex relationship to the enddiastolic volume and pressure, both of which are reduced by dilatation of the capacitance vessels with reduction of venous return due to peripheral pooling.
Ventricular afterload may be defined as the external opposition to the ejection of blood by the ventricle,19,20 and because the ventricle generates pulsatile flow and pressure, the afterload is described best by the aortic input impedance spectrum. In this sense, the impedance is the complex relationship which occurs between pulsatile flow and pulsatile pressure, whereas vascular resistance is the analogous relationship between mean flow and mean pressure (Appendix A).
If the heart were to generate steady flow throughout the vascular system, then it would be required to expend some 5-10 per cent less energy than it needs to because of the requirements of pulsatile flow. The amount of energy expended on the pulsatile components of flow and pressure generation can be used as an inverse index of the efficiency with which the vascular system accepts the pulsatile flow from the heart. The more the pulsatile fraction, the less the efficiency. 21 The relatively low fraction of total work required for pulsatile flow generation demonstrates the remarkable efficiency with which the heart is effectively "uncoupled" from its afterload. 22 The efficiency of this relationship is reduced by vasodilatation, slowing of heart rate and decreased elasticity of the aorta. 21
Anaesthesia and Intensive Care, Vo!. VIII, No. 3, August, 1980 In dogs anaesthetised with halothane, sodium nitroprusside results in an increased ratio of pulsatile to total left ventricular work 23 ,24 so that, although there is a decrease in the steady component of impedance, the increase in the pulsatile components means that there is overall loss of efficiency. Similar effects have been reported by Gersh et al. with trimetaphanY During vasodilatation, the systemic circulation begins to behave like the pulmonary circulation where the power expenditure on oscillatory flow is some 25% of total power. 26 Vasodilators then reduce impedence principally because of their ability to lower the steady component which is normally some 10 to 20 times greater than the pulsatile component and which is due to reduction of the peripheral resistance. At the same time the reduction of impedance is rendered somewhat less effective by increases in the amplitude of the higher harmonics due to a loss of elasticity in the arterial system. In the experimental situation this loss of efficiency is compounded by reduction of heart rate and by increasing rigidity of the aorta. 21
Systemic responses to vasodilatation
When considering the cardiovascular responses to different vasodilator drugs there are certain changes which are 'common to almost all drugs in current usage and which are relatively predictable; and there are other responses which may be relatively exclusive to some agents alone, either because of specificity for localised receptors or vascular groups, or because they are dependent upon a narrow range of dosage or a particular route of administration. 12,27 Sodium nitroprusside has been extensively investigated since its introduction to clinical usage 28 ,29 and makes a useful yardstick with which to compare other agents which were administered acutely. The general responses to vasodilatation with sodium nitroprusside include reduction of systemic arterial pressures, peripheral vascular resistance and aortic impedance. Pulmonary vascular pressures and resistance are also reduced and there is a reduction of left ventricular enddiastolic pressures. 24 ,27,30,31 Cardiac output may increase, 27 ,30,32,33 decrease 34 ,35 or remain unchanged. 24 ,36 The general conclusions to be drawn are that cardiac output will increase due to afterload reduction when left ventricular filling pressures are elevated or maintained high enough to provide adequate preload (10-12 mm Hg). Cardiac output will tend to fall when left ventricular filling pressures are allowed to fall. When sodium nitroprusside is given to patients with normal left ventricular filling pressures cardiac output is likely to change little owing to the reduction in both preload and afterload which cancel out the effect on stroke volume. 31 When filling pressure is low initially, compensatory tachycardia may result. 37 Clearly, prediction of the haemodynamic responses to sodium nitroprusside requires measurement of an index of left ventricular filling pressure.
The reduction of left ventricular filling pressures by sodium nitroprusside is in part due to dilatation of capacitance vessels, partly due to increased ejection fraction and partly to the shift in the left ventricular diastolic pressurevolume relationship. Downward displacement of the left ventricular pressure volume curves in patients with congestive cardiac failure has been recorded by Brodie et al. 38 This would give a lower left ventricular pressure for a given filling volume. Similar changes have been recorded in both normal subjects and in patients with ischaemic heart disease when given glyceryl trinitrate. 39 The relative efficacy of vasodilator drugs on arteriolar resistance and venous capacitance is the subject of incomplete agreement, but is of considerable practical importance. Miller et al., in a comparative study using the human forearm, showed that nitroprusside produced relatively even relaxation of both arteriolar and venous tone, as compared with glyceryl trinitrate which produced predominately venous dilatation and phentolamine which mainly reduced arteriolar toneY Preferential relaxation of venous smooth muscle by glyceryl trinitrate in vitro, whether contracted by potassium or noradrenaline, has also been demonstrated by MacKenzie and Parratt. 16 Collier et al. however, also using the forearm, but with venous tone stimulated with noradrenaline, found that both nitroprusside and glyceryl trinitrate were predominately venodilators and relatively equal in their effect. 40 In patients with coronary artery disease and congestive cardiac failure sublingually administered glyceryl trinitrate relaxed venous smooth muscle relatively more than intravenous nitroprusside which had relatively even arteriolar and venous effects. 27 On the other hand when given by the intravenous route there may be less distinction between glyceryl trinitrate and nitroprusside. 41 ,12,42 However when individual vascular beds are considered there are more clearcut differences between these drugs.
Coronary Circulation and Myocardial Metabolism
The sequestration of blood volume into capacitance vessels, resulting in reduction of left ventricular volume and hence pressure, smaller heart chamber and reduction of wall stress during systole, is the principal mechanism of therapeutic action of glyceryl trinitrate in myocardial ischaemia. 3 ,12,13 However, reduction of end-diastolic volumes may also result from the increased stroke volume which accompanies impedance reduction by arteriolar dilatation. 37 In addition, a third mechanism of producing a reduction of myocardial oxygen demand has been mentioned in terms of the favourable shift in left ventricular diastolic pressure/volume relationship downwards which accompanies vasodilatation. 39 This may be of particular importance in those patients who show a decrease in ventricular wall "compliance" during ischaemia. 43 ,44 Changes in coronary blood flow during the administration of vasodilator drugs are variable both in animals and in man, and are likely to reflect changes in the metabolic requirements of the myocardium. In dogs, given the relatively high dose of sodium nitroprusside of 8 /Ag/kg/min, Rowe and Henderson found an increase in both coronary blood flow and measured myocardial oxygen consumption. 30 Similar increases in both coronary blood flow and myocardial oxygen consumption at lower infusion rates were abolished by autonomic blockade, demonstrating that reflex responses to nitroprusside may stimulate myocardial oxygen needs. 45 In patients with ischaemic heart disease such stimulation may be unfavourable. At low doses sodium nitroprusside may reduce myocardial oxygen needs by a reduction in the determinants of oxygen demand 46 ,47 but at higher doses reflex myocardial stimulation and/or redistribution of myocardial blood flow secondary to direct coronary vasodilatation may provoke ischaemia. 48 ,49 Glyceryl trinitrate, because of its ability to preferentially dilate larger supply arteries rather than smaller resistance arteries,50,51 may be less likely to produce a "steal" effect from an ischaemic region of myocardium. However, this mechanism has been questioned by Foreman et al., who were able to demonstrate such a steal after partial occlusion of a coronary artery in the anaesthetised dog. 52 
Cerebral Circulation
Results of investigations into the behaviour of the cerebral circulation under conditions of vasodilatation are difficult to interpret and sometimes conflicting. Variations occur between drugs used, species studied, the presence of pathology, measurement techniques and indices of perfusion used. An index of the adequacy of cerebral perfusion is the integrity of autoregulation which in the cerebral circulation is the ability to maintain a total blood flow suitable for metabolic requirements despite changes in cerebral perfusion pressure.
Most studies in anaesthetised man have used a combination of drugs and postural changes to produce simultaneous surgical anaesthesia and hypotension. Although results of these studies are highly relevant to the clinical usage of vasodilator drugs, it is usually not possible to delineate responses to the vasodilator drugs from the effects of anaesthesia and postural changes.
Autoregulation was maintained with reduction of mean arterial pressures down to [45] [46] [47] [48] [49] [50] mm Hg with a combination of halothane and trimetaphan. 53 ,54 The latter group also found autoregulation was maintained at least down to this level with a combination of halothane and nitroprusside and with halothane alone. In conscious man however, using combination of trimetaphan and postural changes, Strandgaard et al. found that the lower limit for autoregulation in their subjects was about 60 mm Hg mean arterial pressure, and this lower limit was shifted upwards in hypertensive subjects in proportion to the resting arterial pressure, reaching values of over 100 mm Hg.55 Another disturbing feature of loss of autoregulation is that this impairment may Anaesthesia and Intensive Care, Vol. VIII, No. 3, August, 1980 persist for some time after the return of arterial pressures to resting levels. 56 Recently, Turner et al. studied changes in intracranial pressure (lCP) in neurosurgical patients in whom sodium nitroprusside was used to lower arterial pressure. 57 During the intravenous infusion of nitroprusside they found that ICP rose until mean arterial pressure was reduced to 70 per cent of resting level or less, when ICP began to fall. By contrast, trimetaphan did not appear to alter intracranial pressure overall in a second group studied, although two patients from the group did show a rise in ICP. The reasons suggested for the difference include a possible faster action of nitroprusside, and Fitch has recommended both a slow reduction of arterial pressure when nitroprusside is used and similarly slow restoration back to normal after a period of hypotension, although quantitative recommendations on rates of pressure change will require further investigation. 58 Appendix A NOTE ON DERIVATION OF THE IMPEDANCE SPECTRUM Any repeating of or periodic physiological waveform (such as arterial pressure or blood flow) can be expressed as the sum of a series of sinusoidal waveforms and a constant component representing the mean value. Such a series is called a Fourier series. The sinusoidal waveforms are termed harmonics and each harmonic has three major properties which are (a) its frequency (b) its amplitude (also called the modulus) and (c) its phase angle. The last is a representation of the timing of the harmonic in relation to the other harmonics of the series.
At anyone frequency, the impedance is obtained from the ratio of the amplitude of the pressure harmonic to that of the flow harmonic at that frequency. The various impedance amplitudes are often plotted on a vertical axis with frequency on the horizontal axis to give an impedance spectrum.
In the aortic impedance spectrum the highest amplitude occurs at zero frequency and falls rapidly through the low frequencies to reach a broad minimum at about 12 Hz (McDonald, 1974) .
The phase angle of the impedance at each frequency is obtained by subtracting the phase angle of flow from that of pressure at that frequency. At low frequencies (1-4 Hz) the phase angle in the aorta is negative, that is, pressure lags behind flow. The phase angle of the impedance will be negative when flow leads the pressure and positive when pressure leads the flow.
The ratio of the amplitudes at zero frequency is the ratio of mean flow to mean pressure and is the non-pulsatile component of the impedance, the value generally called vascular resistance. The combination of the amplitudes at the other frequencies form the pulsati1e component of the impedance. The relative contributions to the total impedance made by individual frequencies will change under the influence of vasoactive drugs. This is discussed in more detail by Milnor,20 and McDonald. 1 9
